SCHEMBL3910329

SCHEMBL3910329

CO[C@H](C)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28635102 1.00
SCHEMBL195285 1.00
SCHEMBL387923 0.86 TSHR (0.46)
SCHEMBL6386011 0.84 ALDH1A1 (0.48)
SCHEMBL1438637 0.82 ALDH1A1 (0.52)
SCHEMBL7646382 0.82 ALDH1A1 (0.52)
SCHEMBL10439675 0.80
SCHEMBL10042367 0.79 FOLH1 (0.45)
SCHEMBL2311610 0.78
SCHEMBL5506409 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898633-A1 SUBSTITUTED OXOPYRIDINE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-10-27 EP disclosed
CN-113474348-A Substituted oxopyridine derivatives 拜耳公司 2021-10-01 CN disclosed
EP-3877125-A1 COVERED PANEL AND METHOD FOR MANUFACTURING COVERED PANELS Flooring Industries Limited, SARL (LU) 2021-09-15 EP disclosed
WO-2020127504-A1 SUBSTITUTED OXOPYRIDINE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2020-06-25 WO disclosed
EP-2018862-A1 Substituted piperidines as therapeutic compounds Speedel Experimenta AG (CH) 2009-01-28 EP disclosed